Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent ...

Peanuts offer a nutritional boost with protein, healthy fats, and fiber, aiding heart health and energy. However, moderation ...

Hypereosinophilic syndrome (HES) is a heterogeneous disorder characterised by persistent, abnormal eosinophil elevation in ...

The Company will conduct its third quarter investor conference call today, November 5, 2025, at 8:30 a.m. ET. The audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https: ...

Pakistan's agriculture sector, once the country's economic mainstay, is fast sliding into crisis as surging production costs ...

Researchers in Osaka have found that stem cells from fat tissue can repair spinal fractures similar to those caused by ...

For the first time, researchers at the Technical University of Munich (TUM) have succeeded in using nanorobots to stimulate ...

Every human face is unique, allowing us to distinguish between individuals. We know little about how facial features are ...

DelveInsight's Rheumatoid Arthritis Market Insights report includes a comprehensive understanding of current treatment practices, rheumatoid arthritis emerging drugs, market share of individual ...

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a ...

Rubellite Energy Corp. ("Rubellite" or the "Company"), is pleased to report its third quarter 2025 financial and operating results and provide an operations and guidance update.

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a previously announced debt-facility, are expected to pr ...